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Abstract. According to the International Diabetes Federation, the challenge of early stage diagnosis and treat-
ment effectiveness monitoring in diabetes is currently one of the highest priorities in modern healthcare. The
potential of combined measurements of skin fluorescence and blood perfusion by the laser Doppler flowmetry
method in diagnostics of low limb diabetes complications was evaluated. Using Monte Carlo probabilistic mod-
eling, the diagnostic volume and depth of the diagnosis were evaluated. The experimental study involved 76
patients with type 2 diabetes mellitus. These patients were divided into two groups depending on the degree of
complications. The control group consisted of 48 healthy volunteers. The local thermal stimulation was selected
as a stimulus on the blood microcirculation system. The experimental studies have shown that diabetic patients
have elevated values of normalized fluorescence amplitudes, as well as a lower perfusion response to local
heating. In the group of people with diabetes with trophic ulcers, these parameters also significantly differ from
the control and diabetes only groups. Thus, the intensity of skin fluorescence and level of tissue blood perfusion
can act as markers for various degrees of complications from the beginning of diabetes to the formation of trophic
ulcers. © 2017 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.22.8.085003]
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1 Introduction
According to the International Diabetes Federation (IDF), the
challenge of early stage diagnosis and monitoring of the treat-
ment effectiveness in diabetes is currently one of the highest
priorities in modern healthcare. The medical, social, and eco-
nomic significance of diabetes is primarily determined by the
high prevalence of this disease and the frequency of debilitating
and quality of life-reducing effects suffered by affected individ-
uals. The IDF report for 2015 indicated that there are 415 mil-
lion diabetic patients worldwide, with this figure projected to
grow to 642 million by 2040.1
Over the last several years, multiple studies have indicated
that a timely diagnosis and treatment, including an increased
level of patient monitoring, reduce the manifestation of various
complications, potentially even reversing them at early preclini-
cal stages. Particular attention is given to foot complications
such as peripheral arterial disease (PAD), neuropathy, and skin
disorders including foot ulcers, which are liable for more hos-
pitalizations than any other complication of diabetes.2 Particu-
larly of interest, however, are vascular disorders such as PAD,
which lead to the most adverse implications for patients. Macro-
and microcirculatory disturbances, which are often impercep-
tibly formed, significantly reduce the patient’s life quality. This
can eventually lead to an early death of the patient. Disorders of
microcirculation can occur long before the clinical manifestation
of diabetes and play a central role in the development of foot
ulcers and their subsequent inability to heal.3–7
Available diagnostic approaches for the investigation of PAD
at the level of macro- and microcirculation offer both advantages
and disadvantages inherent to each method. Currently, the com-
monly employed standards of diabetic foot disorder detection in
hospitals or surgery are predominantly thorough medical history
examination, visual inspection, and duplex ultrasonography
scanning of arteries. The latter methods are capable of determin-
ing the level of trophic disorders, specifically the hemodynam-
ics. However, for microcirculatory disturbances, ultrasound
Doppler is not efficient enough.8 Other methods such as radio-
contrast angiography have significant limitations during regular
patient control: invasiveness, contrast agent toxicity, and pro-
longed exposure of the patient to radiation.9,10 In addition to the
methods, medical device manufacturers offer solutions that allow
for a joint diagnosis of macrovascular [measurement of ankle
brachial index, toe brachial index, pulse volume recording, and
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segmental pressure (SP) with measurement under ultrasonic or
laser Doppler flowmetry control]11,12 and microvascular (trans-
cutaneous oximetry) disorders. Often, this allows the acquisition
of qualitative information about PADs and assessment of the
wound-healing potential. However, the interpretation of the
described parameters of vascular disorders can be somewhat
subjective. The measurement results are affected by arterial cal-
cifications as well as the rigidity of the vascular wall.13–15 Also,
it is known that these methods can underestimate the true preva-
lence of cardiovascular diseases and, in particular, do not detect
an early phase of vascular complications.16 The method of trans-
cutaneous oximetry (TcpO2) allows assessment of the oxygen
partial pressure in the intercellular liquids.17,18 Due to physio-
logical, methodological, and technical obstacles, this approach
was not widely used in polyclinic diagnostics. At the same time,
the trustworthiness of data obtained by this method could be
questioned because of low selectivity to infectious inflammation
on the foot, peripheral edema, and other accompanying
pathologies.19,20 Another conventionally employed approach is
thermal imaging, which reveals thermal asymmetry zones on the
limb surface. The result of the diagnostics, however, is usually
meaningful only during late stages of the limb angiopathy,
when the blood circulation is damaged on the level of great
vessels.21,22
Additionally, to date, a general drawback of the methods
available in the physician’s arsenal is the inability to monitor the
metabolic processes occurring in biological tissue. Patients with
diabetes often display severe disorders of microcirculation,
accompanied by significant metabolic shifts. Consequently,
oxygen transport, its delivery, and tissue consumption are the
most important indicators of the functioning of life support sys-
tems, and their adequate evaluation is important for choosing the
optimal methods and tactics for treating each individual patient.
Despite this, there is little information on the effect of
changes in blood flow in the delivery of oxygen and tissue
metabolism of the lower limbs in diabetes mellitus. The influ-
ence of the development of diabetes on foot metabolism has not
been practically investigated at present.4 The main purpose of
this article was to show a possible approach in assessing not
only vascular disorders occurring in diabetes mellitus but
also associated metabolic disorders.
It is known that variations in the respiratory chain enzyme
activities are recognized as one of the consequences resulting
from a breach in the cell function observable in diabetes melli-
tus.23–25 Currently, a lot of research is being done to study the
metabolism of epithelial tissues, including skin, using fluores-
cence spectroscopy and imaging techniques.26–30 Changes in the
mitochondrial respiratory chain are recognized as one of the
consequences resulting from a breach in the cell function
observable in different pathologies. The most likely changes to
occur are the accumulation of a coenzyme nicotinamide adenine
dinucleotide (NADH) (the reduced form) and flavin adenine
dinucleotide (FAD) (oxidized form). Detection of such changes
by fluorescence spectroscopy is one of the most promising
directions for in vivo diagnosis.
A recent review31,32 and some other studies show that
changes in the fluorescence of the NADH respiratory chain were
measured in single cells,33,34 tissue slices,35 and organs.36–39
Despite the fact that the study of NADH and FAD fluorescence
has been successfully held for the past 50 years, relatively little
research has been conducted at the organ level. Meanwhile, the
results of experiments on a particular organ or area of the
body can be more successfully extrapolated to clinical practice
in comparison to the studies at the cellular and subcellular levels.
Furthermore, it has been established in recent years that long-
existing diabetes with hyperglycemia results in an increase in
protein glycation levels. This is accompanied by an increase in
so-called advanced glycation end products (AGEs), which influ-
ence the properties of collagen and other structural proteins of
the capillary membrane and skin.40–43 Among a number of AGE
(e.g., Nε-carboxymethyllysine, Nε-carboxyethyllysine, and pyr-
raline), pentosidine, responsible for the formation of adhesions
between collagen fibers, has its own fluorescence.44–46
Thus, the development of new optical diagnostic methods in
these latter days has potential to find promising application in
diagnosing diabetes disorders. The advantage of these methods
lies in their noninvasive properties, good spatial resolution, low
cost procedures, and high productivity. One of the promising
directions of optical diagnostics development is the establish-
ment of a scientific and instrumental framework to create rapid
and real-time in vivo analysis methods for determining biologi-
cal tissue viability.47
For a comprehensive diagnosis of the state of microcircula-
tory-tissue systems, applying several diagnostic technologies
simultaneously in one diagnostic volume is currently promis-
ing.31,48,49 To assess the state of blood flow and detect possible
vascular disorders, different combinations of methods are
applied. For instance, simultaneous measurements of the inten-
sities of fluorescence and Rayleigh components in human eye
lenses allow a good accuracy to separate patients with diabetes
from a control group.50 Furthermore, diffuse reflectance spec-
troscopy can be used for correction of the data obtained during
fluorescence studies.51,52 Another example of combined tech-
nologies is a lightguide tissue spectrophotometry (O2C). It is a
combination of LDF and tissue spectrometry. This method
allows for the measurement of both relative blood flow by the
laser Doppler technique and hemoglobin oxygenation and
hemoglobin amount in tissue by spectrometric techniques.53
In this study, we experimentally estimate the potential of cor-
egistering cutaneous blood flow parameters and the intrinsic tis-
sue fluorophore fluorescence to distinguish stages of the
complications of lower extremities in patients with diabetes mel-
litus. From the point of view of the fluorescence analysis, it is
logical to consider a complex parameter, which describes the
oxidative metabolic processes (changing the contents of NADH
and FAD) and the carbohydrate metabolism (AGEs accumula-
tion) in tissue, related to patients with diabetes manifesting as
complications of the lower limbs.
2 Material and Methods
2.1 Experimental Equipment
In the experimental studies, the tissue blood perfusion and
the tissue fluorescence were assessed by LDF and FS,
respectively.54 Registered perfusion parameters and the ampli-
tude of the coenzymes’ fluorescence were simultaneously evalu-
ated using a specially designed system in the same tissue volume
(SPE “LAZMA” Ltd., Russia). The Doppler channel built on the
basis of the single-mode laser module used a wavelength of
1064 nm. A 365-nm and 450-nm radiation sources were used for
fluorescence excitation. A multioptical fiber probe was used for
delivery of penetrating radiation and registration of backre-
flected secondary radiation from the tissue [Fig. 1(a)]. The prob-
ing fiber of the LDF channel has a diameter of 6 μm and the
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receiving fiber has a diameter of 400 μm.55 The source-detector
spacing for the LDF channel is 1.5 mm. In the FS channel, diam-
eters of all probing and receiving fibers are 400 μm. For safety
reasons, as well as to keep photobleaching of the tissue at an
acceptable level, probe radiation power of the 365-nm excitation
wavelength at the output of the fiber probe did not exceed
1.5 mW. To assess the safety of the probe, coupled with the
LED, we used documentation of the International Commission
on Nonionizing Radiation Protection (ICNIRP).56 The calcula-
tion gives the effective skin irradiance of 1.4 W∕m2. According
to the cited guideline document, the limiting UVexposure dura-
tion per day for the level of effective irradiance is at least 10 s.
During this protocol, the actual time of the UV-irradiation did
not exceed 1 s. Therefore, from the point of view of the ICNIRP
recommendations, the proposed protocol of using the probe was
deemed to be safe. The output power for the 450-nm excitation
wavelength did not exceed 3.5 mW. The source-detector spacing
for the FS channel was 1 mm. The numerical aperture of the
fibers was 0.22.
Specialized software was developed to work with the system.
This allowed for real-time control of the course of the experi-
ment and analysis of the recorded parameters. It further allowed
the control of the unit responsible for realizing thermal func-
tional tests.
2.2 Experimental Study
The experimental study involved 76 patients with Caucasian
skin type and with type 2 diabetes mellitus at the Endocrinology
Department of the Orel Regional Clinical Hospital (Orel,
Russia). The study did not include volunteers with cardio-
vascular, bronchopulmonary, or neuroendocrine system disease
comorbidities, nor with diseases of the gastrointestinal tract,
liver, kidneys, blood, and any other serious chronic diseases,
which could have an impact on the diagnostic results. Volun-
teers with a history of alcoholism, drug addiction, and drug abuse
were also excluded. Laboratory parameters were measured
according to standard laboratory procedures. The measurement
of blood pressure was carried out after 5 min of rest, with the
patient in a sitting position. Fourteen people from the patient’s
group were considered to have a more severe course of the dis-
ease (diabetic group 2). The decision on the degree of severity in
each case was taken based on the presence of trophic disorders
in the form of ulcers, analysis of anamnesis, and consultation
with the attending physician. Thus, diabetic group 2 consisted
of all diabetics with the presence of visible trophic ulcers, and
diabetic group 1 included patients without trophic ulcers.
Patients were examined on the first day of admission to the
clinic. Prior to hospitalization, patients took medication to
reduce high blood glucose levels. The control group consisted
of 48 healthy volunteers (mean age 46 6 years). The partici-
pating volunteer group was collected through an internal univer-
sity advertisement circulated by physical posters and notification
e-mail. The experiments were conducted under established pro-
tocols. The study protocol was approved at a meeting of the ethics
committee at Orel State University named after I.S. Turgenev
from March 11, 2015 (minutes of the meeting No. 7). After
receiving the description of the protocol, all participating volun-
teers signed an informed consent form.
The main characteristics of the studied groups are presented
in Table 1. With a specified probability of 0.01, we can consider
that the compared groups are statistically homogeneous with a
difference in fasting glucose level and body mass index. The
table shows that diabetic group 2 had a longer duration of
diabetes and higher values of creatinine and urea (which may
indicate kidney function is decreased), but these parameters did
not reach statistically significant levels (p < 0.01). However, the
percentage of complications in this group (diabetic polyneurop-
athy, diabetic retinopathy, diabetic nephropathy, and diabetic
microangiopathy of the lower limbs) is statistically significant
compared to diabetic group 1.
The local heating stimulation was selected as a provocative
action on the blood microcirculation system, allowing assessment
of the local regulatory mechanisms of blood flow. Using a special
Fig. 1 (a) The general scheme of the measuring system and (b) localization of the fiber optic probe with
Peltier thermal-pad.
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block “LAZMA-TEST” (SPE “LAZMA” Ltd., Russia), consecu-
tive local cold (25°C) and heat (35°C and 42°C) provocations
were applied for 4 min each. The first stage included registration
of microcirculatory parameters in the basal conditions for a 4-min
period and the recording of a pair of fluorescence spectra. Thus,
the duration of one study was ∼16 min.
In this study, the probe was secured on the dorsal surface of
the foot to a point located on a plateau between the first and
second metatarsal bones [Fig. 1(b)]. We investigated the area
of nonglabrous skin, where changes in blood flow are mediated
by the vessels themselves and by two mechanisms of the sym-
pathetic nervous system: noradrenergic vasoconstrictor nerves
and a cholinergic active vasodilator system.57 It is due to this
that the bulk of the literature58,59 is focused on controls of the
nonglabrous skin with less focus on the glabrous skin of the
palms, soles, and digits. Moreover, some research stated that
perfusion in the sites with arteriovenous anastomoses (with gla-
brous or nonhairy skin) may fluctuate substantially,60,61 so the
microcirculation assessment in this area may not be a very sen-
sitive indicator of disease severity.62 Particular attention was
paid to minimize local pressure of the probe on skin, as the
parameter strongly influences the measurement results of skin
blood perfusion and fluorescence intensity.63 All studies were
performed in the supine position. The volunteers were asked to
refrain from food and drink 2 h before the study to exclude the
influence of these factors on the change of microhemocirculation
and metabolic processes. Room temperature was maintained at
a steady 24°C to 25°C. All volunteers underwent preliminary
adaptation to these conditions for at least 10 min. Further-
more, skin temperature change of volunteers was recorded dur-
ing the study. In the basal conditions, subjects had different skin
temperatures. In this regard, to unify measurements, we pre-
cooled the study area on the foot to 25°C.
2.3 Validation of Diagnostic Depth of the Probe
Proper evaluation of fluorescence intensity measurements in
healthy tissue and areas of pathology will be possible if the pen-
etration depth of the radiation, as well as diagnostic volume, was
known. It is also important for the researcher or practicing
physician to understand the depth of penetration of probing radi-
ation in laser Doppler measurements for a specific measuring
device.64 This would provide information on the blood vessels
involved in the formation of the signal.
Due to the complexity of the actual sensing conditions, as
well as a complex composite structure of human skin, it is not
possible to obtain a general analytical solution to evaluate the
diagnostic volume. In this regard, the method of stochastic
Monte Carlo (MC) simulations was used. Currently, there are
some known realizations of this approach used to simulate the
propagation of optical radiation in organic tissues.65–67 One of
the more advanced approaches is the use of an object-oriented
Table 1 Statistical difference between patient groups and data for controls.
Characteristics Diabetic group 1 Diabetic group 2 Control group P value
Sex (M/F) 20∕42 8∕6 30∕18 0.08
Age (y) 54 10 53 13 46 6 0.89
Systolic BP (mmHg) 136 16 144 22 128 9 0.29
Diastolic BP (mmHg) 83 8 85 8 80 5 0.12
Body mass index (kg∕m2) 31.9 6.3 32.0 6.2 24.2 2.5 <0.001a
Fasting glucose (mmol/l) 9.3 4.8 9.1 2.5 4.8 0.4 <0.001a
Diabetes duration (y) 11 7 18 12 — 0.03b
HbA1c (%) 8.6 1.5 8.6 0.7 — 0.28b
HbA1c (mmol/mol) 70 9 70 4 — 0.31b
Total cholesterol (mmol/l) 4.9 1.2 5.1 1.3 — 0.76b
Creatinine (μmol∕l) 81.5 28.7 90.3 16.9 — 0.02b
Urea (mmol/l) 7.7 6.8 8.2 2.3 0.09b
ALT (IU/L) 34.2 20.3 28.4 19.3 0.25b
AST (IU/L) 31.0 24.8 24.1 13.4 0.13b
The presence of complications (% of the total number of patients) 15 50 — 0.007b
Note: Data are mean ± SD unless stated otherwise.
Note: Reference values of the laboratory: HbA1c 4.0% to 6.0%, total cholesterol 3.5 to 5.0 mmol∕l, urea 2.5 to 7.5 mmol∕l, creatinine 70 to
110 μmol∕l, ALT 10 to 38 IU∕L, and AST 10 to 40 IU∕L.
aControl group versus diabetic group 1 and diabetic group 2.
bDiabetic group 1 versus diabetic group 2. Nonparametric data of the three studied groups were analyzed by a Kruskal–Wallis analysis of variance
(ANOVA). A Mann–Whitney U-test was used to identify differences between the two groups.
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MC model,68–71 which allows for the description of the photons
and the structural components of the tissue as independent
objects interacting with each other. For acceleration of simula-
tion performance, parallel computing was implemented on the
used algorithms. Parallel computing technology CUDA
(Computer Unified Device Architecture, NVIDIA Corporation)
was employed as a framework of the calculations.
For both the LDF measurements and the fluorescence mea-
surements, the diagnostic volume was assessed through an
evaluation of the probe radiation distribution. For fluorescence
measurements, the validity of this approach is based on the fact
that, according to the rule of Stokes shift, the fluorescence spec-
trum is shifted into the long-wave region. It is also known that
the absorption of light in most of the biological tissues for wave-
lengths of visible spectrum falls as wavelength increases. Thus,
to get a lower-bound estimate of the diagnostic volume of the
measurements, assessing the sampling volume of the radiation
for a wavelength of fluorescence excitation is sufficient. One of
the possible ways to formalize calculation of the sampling vol-
ume is calculating the distribution of rays reaching the detector
using the MC method.
A seven-layer tissue model was used to simulate the diagnos-
tic volume and depth of penetration of the probe radiation. This
model was originally proposed in an earlier article.68 Figure 2(a)
shows an example of the distribution obtained for the above sim-
ulation parameters for a wavelength of 365 nm. Thus, diagnostic
depth of the conducted diagnostics is at least several hundred
microns and includes the epidermis, papillary dermis layer, and
small part of upper blood net dermis [Fig. 2(a)]. Diagnostic vol-
ume, estimated by simulation, is in the order of 0.2 mm3.
For an excitation wavelength of 450 nm, diagnostic depth
reaches 450 to 500 μm and penetrates the epidermis, papillary
dermis, and most of the upper blood net dermis [Fig. 2(b)]. In
this case, the diagnostic volume is approximately estimated by
the simulation as 0.35 mm3.
The performed simulation shows that the proposed probe
allows for the registration of fluorescence in the epidermis,
mainly contributed to by NADH and FAD, and the dermis with
a significant contribution from collagen.
The results of diagnostic volume modeling for the LDF
probe show that the value is about 1.8 mm3. This confirms that
this probe of the developed device is highly sensitive to the
variations of blood flows in the papillary dermis and upper
blood net plexus and is able to cover the top part of the reticular
dermis (Fig. 3).
2.4 Data Analysis
The recorded and subsequently averaged amplitudes AF460 of
the fluorescence at 460 10 nm with excitation at 365 nm and
AF525 of the fluorescence at 525 10 nm with excitation at
450 nm (normalized to the intensity of the backscattered exci-
tation radiation), as well as the average blood tissue perfusion Im
at each stage of the functional test, were analyzed. The wave-
lengths were selected to maximize the probability of detection of
NADH and FAD signals. Taking into account the relatively
small sample sizes, nonparametric methods were used to con-
firm the reliability of differences in the results even in small
groups of observations, namely the Mann–Whitney U-test and
Kruskal–Walles ANOVA test. Values of p < 0.01 were consid-
ered significant.
Considering the former division of experimental data into
classes (two patient and one control), a linear discriminant
Fig. 2 Result of the modeling of diagnostic volume for the fluorescence measurements for the excitation
wavelength of (a) 365 and (b) 450 nm for the parameters of the used optical fiber probe: the distance
between the fibers: 1 mm, fiber diameter: 400 μm, receiving aperture angle: 0.22.
Fig. 3 The result of modeling the diagnostic volume for the LDF mea-
surements for the wavelength of 1064 nm, using the following optical
fiber probe parameters: distance between the fibers: 1.5 mm and
receiving aperture angle: 0.22.
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analysis was employed to determine the discriminant function,
leading to the synthesis of the desired decision rule. The
obtained classifiers allow for a reappearing object to be assigned
to one of the above classes by measured parameter values.
Evaluation of the discriminant analysis quality was performed
using the receiver operating characteristic (ROC) curve.
3 Experimental Results and Discussion
3.1 Experimental Study
Experimental studies have shown that diabetic patients have
elevated values of normalized fluorescence amplitudes, as well
as a lower perfusion response to local heating (up to 35°C and
42°C). At the same time, in the group of diabetic patients with
trophic ulcers (diabetic group 2), these parameters also signi-
ficantly differ from the control and diabetes only groups
(Table 2, Fig. 4).
As already mentioned, AGEs contribute to the mechanisms
responsible for the development of complications in diabetes.
Formation of intracellular AGEs promotes violation in protein
function, with their accumulation acting as an objective marker
for the tissues glycation. The level of skin fluorescence observed
in our studies is related to the degree of conventional glycation
marker HbA1c as determined in vitro. It is important to note,
however, that the standard measure of glycation using HbA1c
characterizes the glycation processes that occur only in the
short term (around 3 months). Changes in AGE content reflect
long-term processes in the diabetic skin. Considering the long
molecular lifetime of collagen and the stability of AGEs, it is
possible to use skin fluorescence as a measure of the total impact
of hyperglycemia throughout the course of life.
It is known that diabetes can lead to tissue hypoxia.72–74 In
the event of hypoxia, the aerobic cellular respiration pathway is
disrupted, and the mitochondrial NADH oxidation is slowed
down. Additionally, the glycolysis pathway for NADH forma-
tion is activated. In this context, the accumulation of NADH
may act as a sign of tissue hypoxia, with its contribution to
the total fluorescence signal serving as a marker of total oxygen
deficiency in tissues. Meanwhile, the processes of oxidative
phosphorylation exhibit changes in the concentrations of NADH
and FAD, which are very complex, and the dynamics of these
changes may be nonlinear throughout the cell’s lifetime.38,39
This should be taken into account when interpreting the data
received and further researching in this area.
It is also shown that the accumulation of AGEs may suppress
the synthesis of NO in endothelial cells.75–77 This may also
explain the differences in perfusion response to various stimuli.
Basal level does not statistically differ among the compared
groups. However, the proposed functional stimulation in the
form of thermal tests can detect and distinguish between micro-
vascular abnormalities in diabetic patients. The perfusion
increase during a local heating test occurs mainly due to two
mechanisms. The heating of skin to 34°C to 35°C results in acti-
vation of peptidergic nerve fibers. This happens due to the
activation of thermosensitive TRPV1 receptors.78 The vasodila-
tion caused by heating skin to 42°C is associated with a release
of NO from vascular endothelium.79,80 Topographically, both
Table 2 The results of experimental studies.
Parameter
Control
group
Diabetic
group 1
Diabetic
group 2
Fluorescence amplitude
AF460, AU
2.1 0.8 2.7 0.8* 3.8 0.7**
Fluorescence amplitude
AF525, AU
1.2 0.4 1.8 0.7* 2.5 0.6**
Perfusion Im , PU 5.0 1.9 5.3 2.2 3.8 1.6
Perfusion I25°Cm , PU 4.4 1.6 4.7 2.0 3.6 1.4
Perfusion I35°Cm , PU 8.7 3.1 6.6 2.4* 5.0 1.4**
Perfusion I42°Cm , PU 19.9 4.6 12.3 3.5* 9.2 4.6**
*Confirmed statistically significant differences between control group
and diabetic group 1 (p < 0.01).
**Confirmed statistically significant differences between diabetic group
1 and diabetic group 2 (p < 0.01).
Fig. 4 Comparison of parameters among control (red empty bars), diabetic (blue loose shading), and
diabetic with ulcers (green tight shading) groups: (a) the normalized fluorescence amplitude and (b) the
average perfusion in the stages of heating to 35°C and 42°C. In each box, the central line is the median of
the group, while the edges are the 25th and 75th percentiles.
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arterioles and capillaries are involved in local heating. All
aspects of the microvasculature and tissue systems undergo dys-
function during diabetes, including the vascular endothelial and
perivascular nerve fibers. Therefore, the thermal test is patho-
genically justified for diagnosing these disorders during diabe-
tes. A reduction in perfusion growth when skin is heated to 35°C
acts as an objective criterion of sensory nerve fiber dysfunction,
which in turn serves as a component of diabetic neuropathy. The
reduction of perfusion growth in people with diabetes compared
with the control group during skin heating to 42°C reflects
a deficit of endothelium-dependent vasodilation mechanisms
(presumably NO-induced).
3.2 Data Analysis
The analyzed parameters of normalized skin fluorescence
amplitudes and perfusion are proposed for the synthesis of
the decision rule. As stated above, these parameters satisfy the
principles of statistical independence, as well as the significance
of the differences of their values, calculated for the patient and
control groups. The discriminant function is synthesized in such
a way as to provide high sensitivity while providing excellent
specificity. Table 3 summarizes the sensitivity and specificity
for the first classification rule (the control group is compared
with a group of patients without ulcers) for a different combina-
tion of measured parameters. As can be seen from the table, the
lowest level of error is obtained with the combination of fluores-
cence intensity at an excitation wavelength of 365 nm and the
level of stimulation of microcirculatory perfusion at 42°C.
For the second classification rule for the separation of the
diabetic group and diabetic group with ulcers, a sensitivity
and specificity of 0.86 and 0.85, respectively, were obtained.
For better combinations of sensitivity and specificity, Fig. 5(a)
shows the scatter plot of the experimental data with applied dis-
criminant lines that divide the experimental points into three
groups (healthy, diabetic, and diabetic with ulcers). The imme-
diate diagnostic criterion, with the aid of the discriminant func-
tions (D1 and D2), allows for the relation of a newly measured
subject to one of the three groups:
EQ-TARGET;temp:intralink-;e001;326;582

D1 ¼ −2.55 − 0.45AF460 þ 0.23I42°Cm ;
D2 ¼ −1.8þ 1.16AF460 − 0.18I42°Cm : (1)
It can be seen from Fig. 5(a) that the shift toward the top-left
characterizes the deterioration of the patient’s condition and
increase in the risk of development of foot ulcers.
Figure 5(b) shows the ROC curves calculated for the
obtained discriminant functions. To compare the quality of dif-
ferent classifying rules, it is convenient to use the integral char-
acteristic AUC—area under curve. In our case, for both
classification rules—AUC ¼ 0.93. This indicator indicates a
high level of quality of the classifier.
Thus, the skin fluorescence and level of tissue blood perfu-
sion during a local heating test can act as markers for various
stages of diabetes, beginning with early disease, to the advance-
ment and development of trophic ulcers.
4 Conclusion
The obtained experimental results confirm the prospects of the
development of new methods for evaluating metabolic shifts in
diabetes mellitus. The proposed method could be a marker of
diabetic complications. It can also be used to assess therapeutic
Table 3 Sensitivity and specificity for the first classification rule.
Parameter AF460 AF525 I35°Cm I42°Cm AF460, I35°Cm AF460, I42°Cm AF525, I35°Cm AF525, I42°Cm
Sensitivity 0.64 0.77 0.77 0.88 0.75 0.92 0.87 0.90
Specificity 0.7 0.79 0.62 0.81 0.77 0.90 0.77 0.83
Fig. 5 (a) The scatter plot with applied discriminant lines, obtained by linear discriminant analysis method
and (b) ROC-curves for assessing the effectiveness of the classifiers. The healthy group is shown by
squares, the diabetic group by circles, and the diabetic group with ulcers by triangles. For the ROC curve:
dot line: control group versus diabetic group 1; solid line: diabetic group 1 versus diabetic group 2.
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interventions aimed at preventing or reversing the progression of
these diabetic complications.
Modeling and experimental results of this study confirm the
high sensitivity of optical noninvasive methods (laser Doppler
flowmetry and fluorescence spectroscopy) when detecting vio-
lations of biological tissue in type 2 diabetes mellitus. Both
approaches, either individually or in combination, may have
important clinical implications as they may help to identify patients
at risk of developing future problems within their lower limbs.
Improvement of methodological support of optical noninva-
sive diagnosis (convenient and completely safe for the patient)
will make a significant contribution to the fight against diabetes,
which is very relevant given the prevalence of the disease.
There is also further potential to expand the number of clini-
cal investigations and improve the methodology. This will even-
tually allow the methods in question to be introduced into the
practice of the attending physician.
A promising direction for future research within this field is
the differentiation of AGEs and NADH and FAD contributions to
the resultant fluorescence signal. This would allow for separate
studies into the possible pathways of biological tissue violation:
by oxidative phosphorylation and carbohydrate metabolism.
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